90 out of 100 people (90%) will survive their Hodgkin lymphoma for 5 years or more after diagnosis.
The 20-year actuarial rates of survival were 78%, 78%, and 46%, respectively, for patients aged 16 or less, 17 to 39, and 40 years or older at diagnosis. Hodgkin's disease diagnosed at age 40 or older was a significant risk factor for all causes of death.
Long-term survival with Hodgkin lymphoma is hard to estimate due to conditions like secondary cancers that may occur decades after treatment. However, between 15 years and 30 years after Hodgkin lymphoma treatment, people are more likely to die from an unrelated cause than from Hodgkin lymphoma.
around 80 out of 100 (around 80%) will survive their lymphoma for 5 years or more after diagnosis.
The 5-year relative survival rate of people with localized Hodgkin lymphoma is 93%. If the cancer spreads regionally, the 5-year relative survival rate is 95%. If the cancer has spread to different parts of the body, the 5-year relative survival rate is 83%.
90 out of 100 people (90%) will survive their Hodgkin lymphoma for 5 years or more after diagnosis.
Overall, treatment for Hodgkin lymphoma is highly effective and most people with the condition are eventually cured.
Most patients with Hodgkin's disease (especially early stage disease) are successfully treated using modern treatment modalities. Disease relapse usually occurs within the first three years after initial therapy. Late relapses of Hodgkin's disease, occurring after 10 years or even later, are rare (0.6% of cases only).
non-Hodgkin lymphoma depends on each patient's specific situation, but in general, the five-year relative survival rate for Hodgkin lymphoma is higher than that of non-Hodgkin lymphoma. One reason may be that non-Hodgkin lymphoma is often diagnosed when the cancer is more advanced.
Hodgkin lymphoma is a relatively aggressive cancer and can quickly spread through the body. Despite this, it's also one of the most easily treated types of cancer. Your recommended treatment plan will depend on your general health and age, because many of the treatments can put a tremendous strain on the body.
Stage 3 lymphoma is treatable and often curable.
Patients who received salvage treatment experienced the highest mortality from infection (RR, 48.1; 95% CI, 20.8 to 94.7; AER, 7.7 per 10,000 person-years).
While Hodgkin lymphomas are relatively rare, they're the most common cancers in young adults. Every year, more people are living longer after treatment. Most of the time, people are cured of Hodgkin lymphoma because treatment eliminates all signs and symptoms.
The goal of Hodgkin lymphoma treatment is to cure the disease. More than 80 percent of all patients diagnosed with Hodgkin lymphoma can be cured by current treatment approaches. The cure rate is higher, approaching 90 percent, in younger patients and those with early-stage favorable disease.
The distribution of Hodgkin Lymphoma (HL or “Hodgkin's Disease”) is age related and bimodal (two-peaks), with the first peak occurring in early adulthood (especially in individuals ages 20-29 years), and again in late adulthood (55 years and older)2. HL is rare, especially in children.
Follicular lymphoma is usually not considered to be curable, instead categorized as more of a chronic disease. Patients can live for many years with this form of lymphoma.
Lymphoma is considered one of the most treatable forms of cancer if found early. For NHL, the overall five- and 10-year relative survival rates are 69% and 59%, respectively. For Hodgkin's lymphoma, the survival rates are equally improved, with a five-year survival rate of 85% and a 10-year survival rate of 80%.
The survival rate of stage 4 lymphoma is lower than that of the other stages, but doctors can cure the condition in some cases. People with a diagnosis of stage 4 lymphoma should discuss their treatment options and outlook with their doctor.
Some survivors of Hodgkin lymphoma have a higher risk of developing a secondary cancer, especially acute myeloid leukemia (after certain types of chemotherapy, like BEACOPP), non-Hodgkin lymphoma, lung cancer, or breast cancer.
You'll also get blood tests, and sometimes imaging tests like CT or PET scans. If these tests show any signs of cancer, you'll have a biopsy to confirm whether your lymphoma has returned. During this test, the doctor removes part or all of a lymph node.
For classical HL, most relapses typically occur within the first three years following diagnosis, although some relapses occur much later. For patients who relapse or become refractory, secondary therapies are often successful in providing another remission and may even cure the disease.
With lymphoma, the lymph nodes often grow slowly and may be there for months or years before they're noticed. But sometimes they grow very quickly. Usually, the swollen nodes don't hurt. But some people say their lumps ache or are painful.
How long does remission last? Hodgkin lymphoma and high-grade non-Hodgkin lymphoma often goes into complete remission and needs no further treatment. However, some people relapse and need more treatment.
Hodgkin lymphoma isn't infectious and isn't thought to run in families. Although your risk is increased if a first-degree relative (parent, sibling or child) has had lymphoma, it's not clear if this is because of an inherited genetic fault or lifestyle factors.